UMMC Offers New Hope with BiTE Immunotherapy for Lymphoma Patients

When lymphoma returned, Diann Jackson sought innovative treatment options offered at the University of Mississippi Medical Center. She received BiTE immunotherapy, a cutting-edge approach gaining traction for treating fast-growing cancers.

BiTE immunotherapy, or bispecific T-cell engager therapy, is emerging as a key option for patients with aggressive cancers. It works by directing the immune system to target and destroy cancer cells more effectively.

UMMC has expanded access to this precision treatment, providing new hope for patients facing difficult diagnoses. Jackson’s experience underscores the therapy’s potential to improve outcomes for lymphoma and other cancers.

For more information about BiTE therapy at UMMC, visit https://umc.edu/news/News_Articles/2026/04/BiTE-Therapy.html.

Source: Original Article